Literature DB >> 17336778

Drug-induced myoclonus: a French pharmacovigilance database study.

C Brefel-Courbon1, V Gardette, F Ory, J L Montastruc.   

Abstract

Various drugs have been reported to induce myoclonus. However, this adverse event is not well known because of the difficult diagnosis and the lack of pharmaco-epidemiological or controlled studies. As far as we know, there are only case reports. In the literature, antiparkinsonian medications, antipsychotics, antidepressants, anesthetics, opiates and anti-infectious drugs have been reported in the occurrence of myoclonus. In a French pharmacovigilance database study, only 423 reports (0.2%) involved drug-induced myoclonus. The median age of patients was 55 years and 10% of these patients had a concomitant neurological disease. Only 16% of these reports had a strong imputability score (likely). The most frequently involved drugs were anti-infectious (15%), antidepressants (15%), anxiolytics (14%), and opiates agents (12%). Fifty-six percent of these reports were classified as serious adverse event. Concerning outcome, most patients (84%) recovered without sequels.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17336778     DOI: 10.1016/j.neucli.2006.12.003

Source DB:  PubMed          Journal:  Neurophysiol Clin        ISSN: 0987-7053            Impact factor:   3.734


  9 in total

1.  Ifosfamide associated myoclonus-encephalopathy syndrome.

Authors:  Rodolfo Savica; Alejandro A Rabinstein; Keith A Josephs
Journal:  J Neurol       Date:  2011-03-12       Impact factor: 4.849

2.  Multifocal myoclonus induced by haloperidol.

Authors:  Cristina Domínguez; Julián Benito-León; Félix Bermejo-Pareja
Journal:  Neurol Sci       Date:  2009-06-13       Impact factor: 3.307

Review 3.  A novel diagnostic approach to patients with myoclonus.

Authors:  Rodi Zutt; Martje E van Egmond; Jan Willem Elting; Peter Jan van Laar; Oebele F Brouwer; Deborah A Sival; Hubertus P Kremer; Tom J de Koning; Marina A Tijssen
Journal:  Nat Rev Neurol       Date:  2015-11-10       Impact factor: 42.937

4.  Memantine-induced Myoclonus in a Patient with Alzheimer Disease.

Authors:  Aditya A Murgai; Mark S LeDoux
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2015-08-14

Review 5.  The clinical heterogeneity of drug-induced myoclonus: an illustrated review.

Authors:  Sabine Janssen; Bastiaan R Bloem; Bart P van de Warrenburg
Journal:  J Neurol       Date:  2016-12-16       Impact factor: 4.849

Review 6.  Myoclonic Disorders.

Authors:  Olaf Eberhardt; Helge Topka
Journal:  Brain Sci       Date:  2017-08-14

7.  Negative myoclonus associated with tramadol use.

Authors:  Seong Yoon Bae; Se-Jin Lee
Journal:  Yeungnam Univ J Med       Date:  2020-04-23

8.  Antidepressants and movement disorders: a postmarketing study in the world pharmacovigilance database.

Authors:  Alexis Revet; François Montastruc; Anne Roussin; Jean-Philippe Raynaud; Maryse Lapeyre-Mestre; Thi Thu Ha Nguyen
Journal:  BMC Psychiatry       Date:  2020-06-16       Impact factor: 3.630

9.  Negative myoclonus associated with pregabalin.

Authors:  Kwan-Do Park; Min-Ku Kim; Se-Jin Lee
Journal:  Yeungnam Univ J Med       Date:  2018-12-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.